Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung

Clinical trial NCT01013831 · TERMINATED

Trial details

NCT number: NCT01013831
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Dysplasia Metaplasia Pulmonary Precancerous Condition

Start date: 2009-10-01
Primary completion: 2012-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.